Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Insect Physiol ; 57(2): 231-45, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21078327

RESUMO

Gene silencing through RNA interference (RNAi) has revolutionized the study of gene function, particularly in non-model insects. However, in Lepidoptera (moths and butterflies) RNAi has many times proven to be difficult to achieve. Most of the negative results have been anecdotal and the positive experiments have not been collected in such a way that they are possible to analyze. In this review, we have collected detailed data from more than 150 experiments including all to date published and many unpublished experiments. Despite a large variation in the data, trends that are found are that RNAi is particularly successful in the family Saturniidae and in genes involved in immunity. On the contrary, gene expression in epidermal tissues seems to be most difficult to silence. In addition, gene silencing by feeding dsRNA requires high concentrations for success. Possible causes for the variability of success in RNAi experiments in Lepidoptera are discussed. The review also points to a need to further investigate the mechanism of RNAi in lepidopteran insects and its possible connection to the innate immune response. Our general understanding of RNAi in Lepidoptera will be further aided in the future as our public database at http://insectacentral.org/RNAi will continue to gather information on RNAi experiments.


Assuntos
Regulação da Expressão Gênica , Lepidópteros/genética , Lepidópteros/imunologia , Interferência de RNA , Animais , Bases de Dados Genéticas , Epiderme/crescimento & desenvolvimento , Inativação Gênica , Imunidade Inata , Proteínas de Insetos/efeitos dos fármacos , Proteínas de Insetos/genética , Proteínas de Insetos/imunologia , Lepidópteros/efeitos dos fármacos , Lepidópteros/crescimento & desenvolvimento , RNA de Cadeia Dupla/efeitos dos fármacos , Projetos de Pesquisa
2.
Transgenic Res ; 11(2): 161-73, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12054350

RESUMO

The cDNA for bovine spleen trypsin inhibitor (SI), a homologue of bovine pancreatic trypsin inhibitor (BPTI), including the natural mammalian presequence was expressed in tobacco using Agrobacterium tumefaciens-mediated transformation. Stable expression required the N-terminal targeting signal presequence although subcellular localization was not proven. SI was found to exist as two forms, one coinciding with authentic BPTI on western blots and the second marginally larger due to retention of the C-terminal peptide. Both were retained on a trypsin-agarose affinity gel and had inhibitory activity. Newly emergent leaves contained predominantly the large form whereas senescent leaves had little except the fully processed form present. Intermediate-aged leaves showed a gradual change indicating that a slow processing of the inhibitor peptide was occurring. The stability of SI was shown by the presence of protein at high levels in completely senescent leaves. Modifications to the cDNA (3' and 5' changes and minor codon changes) resulted in a 20-fold variation in expression. Expression of modified SI in transgenic tobacco leaves at 0.5% total soluble protein reduced both survival and growth of Helicoverpa armigera larvae feeding on leaves from the late first instar. In larvae surviving for 8 days, midgut trypsin activity was reduced in SI-tobacco fed larvae, while chymotrypsin activity was increased. Activities of leucine aminopeptidase and elastase-like chymotrypsin remained unaltered. The use of SI as an insect resistance factor is discussed.


Assuntos
Lepidópteros/efeitos dos fármacos , Nicotiana/genética , Plantas Geneticamente Modificadas , Baço/metabolismo , Inibidores da Tripsina/metabolismo , Agrobacterium tumefaciens/genética , Animais , Bovinos , Vetores Genéticos , Larva/efeitos dos fármacos , Controle Biológico de Vetores , Nicotiana/parasitologia , Tripsina/metabolismo , Inibidores da Tripsina/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA